{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Aadi Bioscience, Inc."},"Symbol":{"label":"Symbol","value":"AADI"},"Address":{"label":"Address","value":"17383 SUNSET BOULEVARD SUITE A250, PACIFIC PALISADES, California, 90272, United States"},"Phone":{"label":"Phone","value":"+1 424 473-8055"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site."},"CompanyUrl":{"label":"Company Url","value":"https://www.aadibio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Berta Grigorian","title":"Vice President-Clinical Operations"},{"name":"Brendan Delaney","title":"President &amp; Chief Executive Officer"},{"name":"Loretta M. Itri","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}